Federal Register / Vol. 86, No. 29 / Tuesday, February 16, 2021 / Notices 9523 

Dated: February 4, 2021. 

Bruce Tibor Roberts, 

Executive Secretary, DMICC, Office of 

Scientific Program and Policy Analysis, 

National Institute of Diabetes and Digestive 

and Kidney Diseases, National Institutes of 

Health. 

[FR Doc. 2021–03047 Filed 2–12–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR18–877: 

Alzheimer’s Disease Clinical Trials. 

Date: March 10, 2021. 

Time: 9:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Sara Louise Hargrave, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 3170, 

Bethesda, MD 20892, (301) 443–7193, 

hargravesl@mail.nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group; 

Biostatistical Methods and Research Design 

Study Section. 

Date: March 10–12, 2021. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Victoriya Volkova, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3140, 

Bethesda, MD 20892, (301) 594–7781, 

victoriya.volkova@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Biostatistical Methods and Research Design. 

Date: March 12, 2021. 

Time: 9:30 a.m. to 11:30 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Seetha Bhagavan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5194, 

MSC 7846, Bethesda, MD 20892, (301) 237– 

9838, bhagavas@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Cancer Diagnostics and Treatments 

(CDT). 

Date: March 15–16, 2021. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Maria Elena CardenasCorona, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20817, (301) 867–5309, maria.cardenascorona@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PAR Panel: 

Community Interventions to Address the 

Consequences of the COVID–19 Pandemic 

Among Health Disparity and Vulnerable 

Populations. 

Date: March 15–16, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Pia Kristina Peltola, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 435–1266, 

pia.peltola@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Disease Prevention and 

Management, Risk Reduction and Health 

Behavior Change. 

Date: March 15–16, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Michael J. McQuestion, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7808, Bethesda, MD 20892, (301) 480– 

1276, mike.mcquestion@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Infectious 

Diseases and Immunology Research 

Enhancement Review. 

Date: March 15, 2021. 

Time: 9:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Liangbiao Zheng, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3202, 

MSC 7808, Bethesda, MD 20892, (301) 996– 

5819, zhengli@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

HIV/AIDS Intra- and Inter-personal 

Determinants and Behavioral Interventions 

Study Section. 

Date: March 15–16, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Mark P. Rubert, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, (301) 806– 

6596, rubertm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Electronic Nicotine Delivery Systems 

(ENDS): Population, Clinical and Applied 

Prevention Research. 

Date: March 15, 2021. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Miriam Mintzer, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3108, 

MSC 7808, Bethesda, MD 20892, (301) 523– 

0646, mintzermz@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; SBIR/STTR 

Applications in Drug Discovery and 

Development. 

Date: March 15–16, 2021. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sergei Ruvinov, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4158, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

1180, ruvinser@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Electronic Nicotine Delivery Systems 

(ENDS): Population, Clinical and Applied 

Prevention Research. 

Date: March 15, 2021. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Mark A. Vosvick, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3110, 


khammond on DSKJM1Z7X2PROD with NOTICES
9524 Federal Register / Vol. 86, No. 29 / Tuesday, February 16, 2021 / Notices 

Bethesda, MD 20892, (301) 402–4128, 

mark.vosvick@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 9, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–03019 Filed 2–12–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; CTEP Branch and 

Support Contracts Forms and Surveys 

(National Cancer Institute) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30 days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Michael Montello, Pharm. D., Cancer 

Therapy Evaluation Program (CTEP), 

9609 Medical Center Drive, MSC 9742, 

Rockville, MD 20850 or call non-tollfree number 240–276–6080 or Email 

your request, including your address to: 

montellom@mail.nih.gov. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on October 8, 2020, page 63565 

(Vol. 85, No. 196, FR 63565) and 

allowed 60 days for public comment. No 

public comments were received. The 

National Cancer Institute (NCI), 

National Institutes of Health, may not 

conduct or sponsor, and the respondent 

is not required to respond to, an 

information collection that has been 

extended, revised, or implemented on or 

after October 1, 1995, unless it displays 

a currently valid OMB control number. 

In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection Title: CTEP 

Support Contract Forms and Surveys 

(NCI), OMB #0925–0753 Expiration Date 

07/31/2021, REVISION, National Cancer 

Institute (NCI), National Institutes of 

Health (NIH). 

Need and Use of Information 

Collection: The National Cancer 

Institute (NCI) Cancer Therapy 

Evaluation Program (CTEP) and the 

Division of Cancer Prevention (DCP) 

fund an extensive national program of 

cancer research, sponsoring clinical 

trials in cancer prevention, symptom 

management and treatment for qualified 

clinical investigators. As part of this 

effort, CTEP implements programs to 

register clinical site investigators and 

clinical site staff, and to oversee the 

conduct of research at the clinical sites. 

CTEP and DCP also oversee two support 

programs, the NCI Central Institutional 

Review Board (CIRB) and the Cancer 

Trial Support Unit (CTSU). The 

combined systems and processes for 

initiating and managing clinical trials is 

termed the Clinical Oncology Research 

Enterprise (CORE) and represents an 

integrated set of information systems 

and processes which support 

investigator registration, trial oversight, 

patient enrollment, and clinical data 

collection. The information collected is 

required to ensure compliance with 

applicable federal regulations governing 

the conduct of human subjects research 

(45 CFR 46 and 21 CRF 50), and when 

CTEP acts as the Investigational New 

Drug (IND) holder, FDA regulations 

pertaining to the sponsor of clinical 

trials and the selection of qualified 

investigators under 21 CRF 312.53). 

Survey collections assess satisfaction 

and provide feedback to guide 

improvements with processes and 

technology. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

151,792. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of 

respondent 

Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total 

annual 

burden 

hours 

CTSU IRB/Regulatory Approval Transmittal Form 

(Attachment A01).

Health Care Practitioner 2,444 12 2/60 978 

CTSU IRB Certification Form (Attachment A02) .. Health Care Practitioner 2,444 12 10/60 4,888 

Withdrawal from Protocol Participation Form (Attachment A03).Health Care Practitioner 279 1 10/60 47 

Site Addition Form (Attachment A04) ................... Health Care Practitioner 80 12 10/60 160 

CTSU Request for Clinical Brochure (Attachment 

A06).

Health Care Practitioner 360 1 10/60 60 

CTSU Supply Request Form (Attachment A07) .. Health Care Practitioner 90 12 10/60 180 

RTOG 0834 CTSU Data Transmittal Form (Attachment A10).Health Care Practitioner 12 76 10/60 152 

CTSU Patient Enrollment Transmittal Form (Attachment A15).Health Care Practitioner 12 12 10/60 24 

CTSU Transfer Form (Attachment A16) ............... Health Care Practitioner 360 2 10/60 120 

CTSU System Access Request Form (Attachment A17).Health Care Practitioner 180 1 10/60 30 

CTSU OPEN Rave Request Form (Attachment 

A18).

Health Care Practitioner 30 21 10/60 105 


khammond on DSKJM1Z7X2PROD with NOTICES